These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 9868833)

  • 1. [The threat of premature labor: new aspects for management].
    Wertz JP; Frising M; Arendt J
    Bull Soc Sci Med Grand Duche Luxemb; 1998; 135(1):51-8. PubMed ID: 9868833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tocolysis with atosiban: experience in the management of premature labor before 24 weeks of pregnancy.
    Richter ON; Dorn C; van de Vondel P; Ulrich U; Schmolling J
    Arch Gynecol Obstet; 2005 Jun; 272(1):26-30. PubMed ID: 15909190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of premature labor in sheep by a combined treatment of nimesulide, a prostaglandin synthase type 2 inhibitor, and atosiban, an oxytocin receptor antagonist.
    Grigsby PL; Poore KR; Hirst JJ; Jenkin G
    Am J Obstet Gynecol; 2000 Sep; 183(3):649-57. PubMed ID: 10992188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The development and introduction of anti-oxytocic tocolytics.
    Lamont RF
    BJOG; 2003 Apr; 110 Suppl 20():108-12. PubMed ID: 12763125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness and safety of the oxytocin antagonist atosiban versus beta-adrenergic agonists in the treatment of preterm labour. The Worldwide Atosiban versus Beta-agonists Study Group.
    Worldwide Atosiban versus Beta-agonists Study Group
    BJOG; 2001 Feb; 108(2):133-42. PubMed ID: 11236112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of atosiban and ritodrine in external cephalic version.
    Stergiotou I; Talbot F; Yoong W
    Acta Obstet Gynecol Scand; 2007; 86(8):927-9. PubMed ID: 17653876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical practice evaluation of atosiban in preterm labour management in six European countries.
    Fallon A; Fallon UB
    BJOG; 2007 Aug; 114(8):1043; author reply 1043-4. PubMed ID: 17635490
    [No Abstract]   [Full Text] [Related]  

  • 8. A randomised controlled trial of metronidazole for the prevention of preterm birth in women positive for cervicovaginal fetal fibronectin: the PREMET Study.
    Shennan A; Crawshaw S; Briley A; Hawken J; Seed P; Jones G; Poston L
    BJOG; 2006 Jan; 113(1):65-74. PubMed ID: 16398774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Atosiban treatment for preterm labor--financial considerations and savings by implementing clinical guidelines].
    Hadar E; Mansur N; Ambar I; Hod M
    Harefuah; 2011 Jun; 150(6):502-6, 553. PubMed ID: 21800486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atosiban versus usual care for the management of preterm labor.
    Husslein P; Cabero Roura L; Dudenhausen JW; Helmer H; Frydman R; Rizzo N; Schneider D
    J Perinat Med; 2007; 35(4):305-13. PubMed ID: 17614750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infection and premature labor.
    Ledger WJ
    Am J Perinatol; 1989 Apr; 6(2):234-6. PubMed ID: 2712921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No effect of tocolytic therapy with atosiban on maternal serum interleukin-6 and tumor necrosis factor-alpha in threatened preterm labor.
    Vitoratos N; Kountouris A; Makrakis E; Papadias K; Creatsas G
    J Matern Fetal Neonatal Med; 2007 Oct; 20(10):725-8. PubMed ID: 17763273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preterm labour. The present and future of tocolysis.
    Giles W; Bisits A
    Best Pract Res Clin Obstet Gynaecol; 2007 Oct; 21(5):857-68. PubMed ID: 17459777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging tocolytics for maintenance therapy of preterm labour: oxytocin antagonists and calcium channel blockers.
    Kim A; Shim JY
    BJOG; 2006 Dec; 113 Suppl 3():113-5. PubMed ID: 17206978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical practice evaluation of atosiban in preterm labour management in six European countries.
    Husslein P; Roura LC; Dudenhausen J; Helmer H; Frydman R; Rizzo N; Schneider D;
    BJOG; 2006 Dec; 113 Suppl 3():105-10. PubMed ID: 17206976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infection in the prediction and antibiotics in the prevention of spontaneous preterm labour and preterm birth.
    Lamont RF; Sawant SR
    Minerva Ginecol; 2005 Aug; 57(4):423-33. PubMed ID: 16170287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multicentre, parallel group, randomised, single-blind study of the safety and efficacy of atosiban versus ritodrine in the treatment of acute preterm labour in Korean women.
    Shim JY; Park YW; Yoon BH; Cho YK; Yang JH; Lee Y; Kim A
    BJOG; 2006 Nov; 113(11):1228-34. PubMed ID: 16978233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tocolytic therapy and clinical experience. Combination therapy.
    Ingemarsson I
    BJOG; 2005 Mar; 112 Suppl 1():89-93. PubMed ID: 15715603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxytocin receptor blockade: a new principle in the treatment of preterm labor?
    Andersen LF; Lyndrup J; Akerlund M; Melin P
    Am J Perinatol; 1989 Apr; 6(2):196-9. PubMed ID: 2540760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obstetric and neonatal infection.
    Dinsmoor MJ
    Curr Opin Obstet Gynecol; 1991 Oct; 3(5):707-14. PubMed ID: 1958805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.